A new once-daily formulation of tolterodine provides superior efficacy and is well tolerated in women with overactive bladder.
A new once-daily formulation of tolterodine provides superior efficacy and is well tolerated in women with overactive bladder. Int Urogynecol J Pelvic Floor Dysfunct. 2003 Feb; 14(1):50-4; discussion 54-5.